Rationally-Designed Single-Chain Meganucleases with Non-Palindromic Recognition Sequences
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application PCT/US2008/082072, filed Oct 31, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,340,777 | Rationally-Designed Single-Chain Meganucleases with Non-Palindromic Recognition Sequences In force · Medium confidence UsedRemaining | Precision Biosciences, Inc. | In force | Medium confidence | ||
| US 9,434,931 | Rationally-Designed Single-Chain Meganucleases with Non-Palindromic Recognition Sequences In force · Low confidence | Precision Biosciences, Inc. | In force | Low confidence | ||
| US 10,041,053 | Rationally-Designed Single-Chain Meganucleases with Non-Palindromic Recognition Sequences In force · Low confidence | Precision Biosciences, Inc. | In force | Low confidence | ||
| US 12,351,839 | Rationally-Designed Single-Chain Meganucleases with Non-Palindromic Recognition Sequences In force · Low confidence | Precision Biosciences, Inc. | In force | Low confidence | ||
| US 8,445,251 | Rationally-Designed Single-Chain Meganucleases with Non-Palindromic Recognition Sequences In force · Medium confidence | Precision Biosciences, Inc. | In force | Medium confidence | ||
| Application 14/723,840 | Rationally-Designed Single-Chain Meganucleases with Non-Palindromic Recognition Sequences Abandoned Abandoned Dec 11, 2017 | Precision Biosciences, Inc. | Abandoned | Abandoned Dec 11, 2017 | ||
| Application 16/025,747 | Rationally-Designed Single-Chain Meganucleases with Non-Palindromic Recognition Sequences Abandoned Abandoned Jan 25, 2021 | Precision Biosciences, Inc. | Abandoned | Abandoned Jan 25, 2021 | ||
| Application 17/079,377 | Rationally-Designed Single-Chain Meganucleases with Non-Palindromic Recognition Sequences Abandoned Abandoned Apr 25, 2023 | Precision Biosciences, Inc. | Abandoned | Abandoned Apr 25, 2023 | ||
| Application 13/897,923 | Rationally-Designed Single-Chain Meganucleases with Non-Palindromic Recognition Sequences Abandoned Abandoned Aug 25, 2015 | Precision Biosciences, Inc. | Abandoned | Abandoned Aug 25, 2015 | ||
| Application 19/029,758 | Rationally-Designed Single-Chain Meganucleases with Non-Palindromic Recognition Sequences Pending Not granted | Precision Biosciences, Inc. | Pending | Not granted |
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Precision Biosciences, Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.